Calysta Energy Stock

Calysta Energy develops a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using natural gas.

Sign up today and learn more about Calysta Energy Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Calysta Energy Stock

Calysta Energy (, Menlo Park, CA., is developing a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.

Funding History

May 2011$5.0M
December 2013$3.0M
January 2015$10.0M
February 2016$30.0M
May 2017$40.0M


Chief Financial Officer and Chief Sustainability Officer

Lynsey Wenger

Vice President, Biological Engineering

Lori Giver


David McElroy

President and Chief Executive Officer

Alan Shaw

Vice President, Global Capital Projects

Graham Aylen

Chief Product and Innovation Officer

Josh Silverman

Vice President, Business Development

Dennis Leong

Vice President, Nutrition

Arild Johannessen


petfoodprocessing - Jul, 25 2022

Sustainable protein producer debuts new facility

visugram - Dec, 10 2021

Top 30 Animal Feed Startups

strictlyvc - Feb, 6 2016

StrictlyVC: February 2, 2016

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: